Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb;17(2):e011428.
doi: 10.1161/CIRCHEARTFAILURE.123.011428. Epub 2024 Feb 1.

Ongoing Enigma of NT-proBNP in HFpEF: Insights From Proteomics

Peder L Myhre  1   2 , Torbjørn Omland  1   2 , Amil M Shah  3
Affiliations
Editorial

Ongoing Enigma of NT-proBNP in HFpEF: Insights From Proteomics

Peder L Myhre et al. Circ Heart Fail. 2024 Feb.
No abstract available

Keywords: Editorials; biomarkers; heart failure; prognosis; proteome.

PubMed Disclaimer

Conflict of interest statement

Disclosures Dr Myhre reports research grants from AstraZeneca and consulting and speaker fees from Amarin, AmGen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Novartis, Novo Nordisk, Orion Pharma, Pharmacosmos, Vifor, and Us2.ai. Dr Omland reports research support from Abbott Diagnostics, ChromaDex, Novartis, and Roche Diagnostics; reports consulting fees and speaker honoraria from Abbott Diagnostics, Bayer, CardiNor, and Roche Diagnostics; and reports stock and stock options from CardiNor. Dr Shah was supported by National Institutes of Health/National Heart, Lung, and Blood Institute grants R01HL135008, R01HL148218, and K24HL152008 and received research support from Novartis through Brigham and Women’s Hospital and consulting fees from Philips Ultrasound and Janssen.

Comment on

References

    1. Myhre PL, Claggett B, Yu B, Skali H, Solomon SD, Røsjø H, Omland T, Wiggins KL, Psaty BM, Floyd JS, et al. Sex and Race Differences in N-Terminal Pro-B-type Natriuretic Peptide Concentration and Absolute Risk of Heart Failure in the Community. JAMA Cardiol. 2022;7:623–631. doi: 10.1001/jamacardio.2022.0680 - DOI - PMC - PubMed
    1. Nayor M, Short MI, Rasheed H, Lin H, Jonasson C, Yang Q, Hveem K, Felix JF, Morrison AC, Wild PS, et al. Aptamer-Based Proteomic Platform Identifies Novel Protein Predictors of Incident Heart Failure and Echocardiographic Traits. Circulation: Heart Failure. 2020;13:e006749. doi: doi:10.1161/CIRCHEARTFAILURE.119.006749 - DOI - PMC - PubMed
    1. Zhang L, Cunningham JW, Claggett BL, Jacob J, Mendelson MM, Serrano-Fernandez P, Kaiser S, Yates DP, Healey M, Chen CW, et al. Aptamer Proteomics for Biomarker Discovery in Heart Failure With Reduced Ejection Fraction. Circulation. 2022;146:1411–1414. doi: 10.1161/circulationaha.122.061481 - DOI - PubMed
    1. Azzo JD, Dib MJ, Zagkos L, Zhao L, Wang Z, Chang CP, Ebert C, Salman O, Gan S, Zamani P, et al. Proteomic Associations of N-terminal (NT)-pro hormone BNP (NT-proBNP) in Heart Failure with Preserved Ejection Fraction (HFpEF). Circ Heart Fail. 2024. In Press. DOI: 10.1161/CIRCHEARTFAILURE.123.011146. - DOI - PMC - PubMed
    1. Wells QS, Gupta DK, Smith JG, Collins SP, Storrow AB, Ferguson J, Smith ML, Pulley JM, Collier S, Wang X, et al. Accelerating Biomarker Discovery Through Electronic Health Records, Automated Biobanking, and Proteomics. J Am Coll Cardiol. 2019;73:2195–2205. doi: 10.1016/j.jacc.2019.01.074 - DOI - PMC - PubMed